title: Protection of adults rechallenged with a human rotavirus.
abstract: Previous studies of adults challenged with human rotavirus (CJN strain) showed that 74% became infected and 55% of those infected experienced illness. Protection against infection correlated with rotavirus antibody, most significantly (P = .005) serum rotavirus IgG. In this study, 20 previously challenged subjects were reinoculated with the same virus 9-12 months after their initial challenge. Only 1 of 8 subjects not infected after the initial challenge and 2 of 12 infected after the first inoculation became infected after reinoculation; none became ill. Titers of rotavirus antibodies (serum, jejunal, and stool) at the time of reinoculation were about as high as or higher than they were before the initial inoculation. This correlated with greater protection, but the extent of protection was significantly greater (P less than .0001) than predicted based on a previous model relating protection and preinoculation titers of serum rotavirus IgG. Thus, inoculation with human rotavirus provided homotypic protection for at least 9-12 months, and protection remained correlated with higher concentrations of rotavirus antibody. However, the specific relationship between protection and rotavirus antibody was altered after the initial inoculation.
authors.affiliation: Division of Clinical Virology, James N. Gamble Institute of Medical Research, Cincinnati, OH 45219.
authors.forename: R L
authors.initials: RL
authors.lastname: Ward
authors.forename: D I
authors.initials: DI
authors.lastname: Bernstein
authors.forename: R
authors.initials: R
authors.lastname: Shukla
authors.forename: M M
authors.initials: MM
authors.lastname: McNeal
authors.forename: J R
authors.initials: JR
authors.lastname: Sherwood
authors.forename: E C
authors.initials: EC
authors.lastname: Young
authors.forename: G M
authors.initials: GM
authors.lastname: Schiff
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007071:Immunoglobulin A, Secretory / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007583:Jejunum / Q000276:immunology; D008297:Male; D011336:Probability; D012008:Recurrence; D012401:Rotavirus / Q000276:immunology*; D012400:Rotavirus Infections / Q000276:immunology* / Q000517:prevention & control
chemical_list: D000914:Antibodies, Viral; D007070:Immunoglobulin A; D007071:Immunoglobulin A, Secretory; D007074:Immunoglobulin G